John Bernard Buse - the UNC Department of Medicine

Buse, Curriculum Vitae p. 12 of 29 Updated: August 2008
3. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B for
the American Diabetes Association and the European Association for Study of Diabetes.
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the
initiation and adjustment of therapy: a consensus statement of the American Diabetes
Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;
32:193-203. (Simultaneously published as Diabetologia. 2009; 52:17-30. )
4. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman
MS, Kosiborod M, Reaven P, Sherwin RS; American Diabetes Association; American
College of Cardiology Foundation; American Heart Association. Intensive glycemic control
and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and
VA diabetes trials: a position statement of the American Diabetes Association and a
scientific statement of the American College of Cardiology Foundation and the American
Heart Association. Diabetes Care. 2009; 32:187-92. (Simultaneously published as
Circulation 2009; 119:351-7 and J Am Coll Cardiol. 2009; 53:298-304.)
5. Buse JB. Are prescribing patterns of antidiabetic medications influenced by fears of
litigation? Nat Clin Pract Endocrinol Metab. 2008; 4:440-1.
6. Hicks J, Muller M, Panteghini M, John G, Deeb L, Buse J, Nathan DM, Kahn R, Ferrannini
E, Heine R, Silink M, Mbanya JC for the American Diabetes Association, European
Association for the Study of Diabetes, International Federation of Clinical Chemistry and
Laboratory Medicine, and the International Diabetes Federation. Consensus statement on the
worldwide standardization of the hemoglobin A1C measurement. Simultaneously published:
Diabetes Care 30:2399-2400, 2007, Clinical Chemistry 53:1562-1564, 2007
7. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues
in setting targets for inpatient management. Diabetes Care 30: 403-409, 2007.
8. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC,
Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ.
Primary prevention of cardiovascular diseases in people with diabetes: a joint statement and
recommendations from the American Diabetes Association and the American Heart
Association. Diabetes Care 30:167-172, 2007 and Circulation 115:114-26, 2007.
9. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B.
Management of hyperglycemia in type 2 diabetes mellitus: A consensus algorithm for the
initiation and adjustment of therapy. Simultaneously published: Diabetes Care 29:1963-
1972, 2006 and Diabetologia 49:1711-21, 2006.
10. Buse JB, Rosenstock J. Prevention of cardiovascular outcomes in type 2 diabetes mellitus:
Trials on the horizon. Cardiology Clinics 23:211-220, 2005.
11. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association, European
Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal:
joint statement from the American Diabetes Association and the European Association for
the Study of Diabetes. Simultaneously publishedL Diabetes Care 28:2289-304, 2005 and
Diabetologia 48:1684-99, 2005.
12. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, Ismail-Beigi F, El-
Kebbi I, Khatib O, Kishawi S, Al-Madani A, Mishal AA, Al-Maskari M, Nakhi AB, Al-
Rubeanm K. Recommendations for management of diabetes during Ramadan. Diabetes Care
28:2305-11, 2005.
13. Hirsch IB, Bergenstal RM, Parkin CG, Wright, Jr., E, Buse JB. A real-world approach to
insulin therapy in primary care practice. Clinical Diabetes 23:78-86, 2005.